VanEck Pharma ETF (PPH) which represents Big Pharma rises despite ongoing industry specific challenges as pharmaceuticals are ...

Eupraxia Pharmaceuticals (NASDAQ:EPRX – Get Free Report) will likely be posting its quarterly earnings results before the market opens on Monday, April 7th. Analysts expect Eupraxia Pharmaceuticals to ...

Phio Pharmaceuticals (NASDAQ:PHIO – Get Free Report) is anticipated to post its quarterly earnings results before the market opens on Monday, April 7th. Analysts expect Phio Pharmaceuticals to post ...

Biotech stocks toppled early Thursday after Trump announced broad global tariffs, including a 20% tariff on goods from Europe ...

相关ETF方面， 港股创新药ETF（159567） 盘中涨逾4%，换手率超20%。成分股方面，药明康德一度涨超15%，现涨13.3%，药明合联、药明生物涨幅随后，康诺亚-B、乐普生物-B等多股涨超5%。

The Invesco Pharmaceuticals ETF (PJP) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.

President Donald Trump on Wednesday announced a slew of tougher-than-anticipated tariffs, but there are some notable ...

You should consider the VanEck Pharmaceutical ETF (PPH), a passively managed exchange traded fund launched on 12/20/2011. An increasingly popular option among retail and institutional investors ...

Involves transaction of at least 0.5% of the listed shares of a company. What was Nippon India NIFTY Pharma ETF Growth Plan share price previously? Nippon India NIFTY Pharma ETF Growth Plan share ...